CITIUS ONCOLOGY, INC.
Public company- Headquarters
- CRANFORD, New Jersey
- Ticker
- CTOR
- CIK
- 0001851484
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Aug 12, 2026
Executive appointmentClass I member of the Board appointed: Jonathan Peri, Ph.D., J.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class I member of the BoardJonathan Peri, Ph.D., J.D. | Aug 12, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- ELITE PHARMACEUTICALS INC /NV/
Class I director appointed: John W. LaRocca, Esq.
- Executive appointment
Class I member of the Board appointed: Jonathan Peri, Ph.D., J.D.
Jonathan Peri, Ph.D., J.D. was named Class I member of the Board of CITIUS ONCOLOGY, INC., effective August 10, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 12, 2026Role: Class I member of the Board
Only one public record so far. We add events as soon as a new filing lands; watch CITIUS ONCOLOGY, INC. to get them in your digest.
Last verified Nov 8, 2026